|
Thomas B. Okarma Ph.D. M.D. has served as the Company’s President Chief Executive Officer and a director since July 1999. He is also a director of Geron Bio-Med Limited a United Kingdom company and the Company’s wholly-owned subsidiary and TA Therapeutics Ltd a Hong Kong company and a joint venture between the Company and Biotechnology Research Corporation of Hong Kong. Dr. Okarma currently serves on the Board of the Biotechnology Industry Organization and is Chairman of the Board of Overseers of Dartmouth Medical School. From May 1998 until July 1999 Dr. Okarma was the Vice President of Research and Development of the Company. From December 1997 until May 1998 Dr. Okarma was Vice President of Cell Therapies of the Company. From 1985 until joining Geron Dr. Okarma the scientific founder of Applied Immune Sciences Inc. served initially as its Vice President of Research and Development and then as its Chairman and Chief Executive Officer until 1995 when it was acquired by Rhone-Poulenc Rorer. Dr. Okarma was a Senior Vice President at Rhone-Poulenc Rorer from the time of the acquisition of Applied Immune Sciences Inc. until December 1996. From 1980 to 1985 Dr. Okarma was a member of the faculty of the Department of Medicine at Stanford University School of Medicine. Dr. Okarma holds an A.B. from Dartmouth College and a M.D. and Ph.D. from Stanford University. | 